Retama para Inflamación crónica y aguda
Senna reticulata — 13 estudios científicos revisados
Moderate¿Sirve Retama para inflamación crónica y aguda?
Finalmente, se han explorado sus efectos antiinflamatorios mediante estudios in vitro en líneas celulares de macrófagos.
Compuestos activos involucrados: Alcaloides, Fenoles, Flavonoides, Glucósidos, Polifenoles, Saponinas, Terpenos, Compuestos fenólicos
Evidencia Científica
Los siguientes estudios han investigado la relación entre Retama y inflamación crónica y aguda:
American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
INTRODUCTION: Chronic idiopathic constipation (CIC) is a common disorder associated with significant impairment in quality of life. This clinical practice guideline, jointly developed by the American Gastroenterological Association and the American College of Gastroenterology, aims to inform clinicians and patients by providing evidence-based practice recommendations for the pharmacological treatment of CIC in adults. METHODS: The American Gastroenterological Association and the American College of Gastroenterology formed a multidisciplinary guideline panel that conducted systematic reviews of
PubMed: 37211380British Dietetic Association Guidelines for the Dietary Management of Chronic Constipation in Adults.
BACKGROUND: Current clinical guidelines for chronic constipation offer limited dietary recommendations. The aim of this project was to develop the first comprehensive evidence-based dietary guidelines for the management of chronic constipation in adults. METHODS: Four systematic reviews and meta-analyses were performed to identify eligible randomised controlled trials (RCTs). The findings generated from the meta-analyses were then used to develop guideline statements using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach and a Delphi consensus survey amon
PubMed: 41081513Non-pharmacologic approach to pediatric constipation.
Functional constipation (FC) is a pervasive problem in pediatrics. Although pharmaceuticals are commonly used for FC, parents and patients show reluctance or find dissatisfaction with available medications at times. Further, patients often have interest in utilizing nutraceutical supplements and botanicals that are available over the counter. This literature review aims to summarize research studies performed on non-pharmacologic approaches to constipation and to evaluate the safety and efficacy of these modalities. Overall data on non-pharmacologic treatments for childhood constipation were s
PubMed: 33737146Is it safe to consume traditional medicinal plants during pregnancy?
The popularity of natural medicine is growing worldwide. Unlike conventional licensed medicines, herbal medicine practices are usually not supported by effectiveness, efficacy, or safety studies, which raise concerns about potential risks involved in their usage, particularly in high-risk patients such as pregnant women where teratogenicity is a concern. Despite a lack of science-based evidence, the use of herbal products for the management of pregnancy-associated challenges is common, due to the common notion that they are free of toxic effects and adverse reactions because they are "natural.
PubMed: 33164294American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
INTRODUCTION: Chronic idiopathic constipation (CIC) is a common disorder associated with significant impairment in quality of life. This clinical practice guideline, jointly developed by the American Gastroenterological Association and the American College of Gastroenterology, aims to inform clinicians and patients by providing evidence-based practice recommendations for the pharmacological treatment of CIC in adults. METHODS: The American Gastroenterological Association and the American College of Gastroenterology formed a multidisciplinary guideline panel that conducted systematic reviews of
PubMed: 37204227Seguridad y Precauciones
La seguridad en el uso de Senna reticulata es un asunto de extrema precaución debido a su potente actividad farmacológica y la presencia de compuestos bioactivos como los glucósidos antraquinónicos. En mujeres embarazadas, el uso de esta planta es estrictamente desaconsejado; los componentes de la especie pueden actuar como agentes oxitócicos, estimulando las contracciones del músculo liso uterino, lo que incrementa el riesgo de parto pretérmino o aborto espontáneo. Durante la lactancia, los metabolitos activos pueden ser excretados a través de la leche materna, lo que representa un riesgo de diarreas profusas y desequilibrio electrolítico en el lactante. En la población pediátrica menor de 12 años, el riesgo de desequilibrio electrolítico es crítico, ya que la pérdida de líquidos puede derivar en una deshidratación aguda y una disminución peligrosa de los niveles de potasio y sodio. En cuanto a las interacciones medicamentosas, la Retama puede interferir con la warfarina debido a que la aceleración del tránsito intestinal altera la ventana de absorción del anticoagulante, modificando su biodisponibilidad y eficacia. Con la metformina, la alteración de la motilidad intestinal puede comprometer la absorción constante del fármaco, afectando el control glucémico.
Otras plantas estudiadas para Inflamación crónica y aguda
Perfil completo: Ver todos los usos y evidencia de Retama →